Edgestream Partners’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Sell
5,575
-22,041
-80% -$793K 0.01% 885
2026
Q1
$677K Buy
27,616
+11,209
+68% +$265K 0.02% 691
2025
Q4
$407K Buy
+16,407
New +$436K 0.01% 845

Other funds holding ASTH

Edgestream Partners's ASTH Position: Q2 2026 in Review

Edgestream Partners reduced its Astrana Health (ASTH) stake by 80% in Q2 2026, selling an estimated $793K and leaving 5,575 shares worth $259K. The position accounts for 0.01% of the portfolio, ranked #885.

Edgestream Partners first reported a position in ASTH in Q4 2025 and has held it in 3 quarters since. The position peaked at $677K in Q1 2026. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Edgestream Partners held 5,575 shares of Astrana Health worth $259K as of Q2 2026.
  • Edgestream Partners sold 22,041 Astrana Health shares in Q2 2026, an estimated $793K.
  • Astrana Health made up 0.01% of Edgestream Partners's portfolio in Q2 2026, its #885 holding.
  • Edgestream Partners first reported a position in Astrana Health in Q4 2025 and has held it in 3 quarters since.
  • Edgestream Partners's Astrana Health position peaked at $677K in Q1 2026.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.